Recent Updates
Recently added Catalysts
SNTI Positive Sentiment

Fran Schulz

Key Takeaway: Fran Schulz has been a board member since 2024, bringing over 35 years of experience from Ernst & Young's Life Sciences Practice. She has played a pivotal role in corporate deals and has raised over $15 billion through various transactions. Currently, she serves on the boards of EDAP TMS SA and Menlo College.
Price reaction · baseline $2.16 (2024-11-29 close) · hit pre-market · 1 other SNTI headline(s) in the window, move may be shared
day 0 close · peak
+363%
day 1
+230.6%
day 3
+187%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ms. Schulz has extensive experience in the life sciences sector.
  • She has contributed to significant growth at EY, a $45B firm.
  • Her involvement in over 100 transactions showcases her expertise.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+84%
120-day peak, hindsight
Typical move
76.7%
average across 4 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
SENTI-202
Phase 1 · AML/MDS

Full Press Release Details

Ms. Schulz has served as a member of our board of directors since 2024. Ms. Schulz was one of the founding members and senior partners in Ernst & Young’s (EY) Life Sciences Practice and has held various roles at EY over 35 years. While at EY, Ms. Schulz directly contributed to the growth of EY into a $45B firm. She is also qualified to serve as a financial expert under SEC, NYSE and NASDAQ rules. Ms. Schulz spent her career working with large public and emerging private companies throughout the life sciences industry. She has deep experience guiding companies to execute a broad range of corporate deals including collaboration agreements, corporate spin-offs, reorganizations, and mergers and acquisitions, with personal involvement in over 100 total equity and debt transactions, raising over $15 billion in aggregate. Ms. Schulz also has significant experience with the U.S. Securities and Exchange Commission and International Financial Reporting Standards.
Ms. Schulz currently serves as a Board Member and Audit Committee Chair of EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, and as a Board Member and Audit Committee Chair of Menlo College.
Ms. Schulz is a certified public accountant (CPA) licensed in California. She received her B.S. in Business Administration from Menlo College.

Frequently Asked Questions

What is Fran Schulz's role at SNTI?

Fran Schulz serves as a member of SNTI's board of directors.

What experience does Fran Schulz have?

She has over 35 years of experience in the life sciences sector at EY.

How many transactions has Fran Schulz been involved in?

She has been personally involved in over 100 equity and debt transactions.

What is Fran Schulz's educational background?

She holds a B.S. in Business Administration from Menlo College.

Last updated: Dec 2, 2024